2023 was a watershed year for women’s reproductive rights in Australia, but the cost of contraception and abortion services remains too high.
While fentanyl is yet to markedly impact Australia, the North American opioid crisis shows us how bad it can get, and urgent action is needed now.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
Changes to the Pharmaceutical Benefits Scheme have influenced the way doctors prescribe opioids, but is it for the better?
This week, Monash University's “What Happens Next?” podcast investigates how making reproductive healthcare inaccessible hurts us all.
A class of drugs developed to treat type 2 diabetes and obesity is in short supply, sparking debate about who should be prioritised for access.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
For only the second time in 60 years, a drug has been approved for the treatment of lupus, a debilitating form of rheumatic disease.
Upcoming trials may offer hope to those who suffer from debilitating cluster headaches and chronic migraines.
Treasurer Josh Frydenberg and PM Scott Morrison pack the 2019 Federal Budget full of goodies as they push towards an election.
The drug epidemic that's claimed thousands of lives in the US is swiftly becoming a threat to the health of many Australians.
HIV is no longer a death sentence, but the epidemic that has claimed nearly 40 million lives and ruined countless others isn’t over yet.
Dummy text